Information on factors leading to pulmonary arterial hypertension (PAH) treatment discontinuation is limited. This study analyzed 12,902 new PAH medication users to identify predictors of treatment discontinuation. Treatment by accredited pulmonary hypertension centers and combination therapy with PAH agents from different classes were less likely to result in discontinuation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11017292 | PMC |
| http://dx.doi.org/10.1002/pul2.12326 | DOI Listing |
Publication Analysis
Top Keywords
discontinuation treatment
8
pulmonary arterial
8
arterial hypertension
8
treatment discontinuation
8
factors associated
4
discontinuation
4
associated discontinuation
4
treatment
4
treatment pulmonary
4
hypertension united
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!